Bradley Foster & Sargent Inc. CT lessened its holdings in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 30.0% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 14,008 shares of the company’s stock after selling 5,995 shares during the period. Bradley Foster & Sargent Inc. CT’s holdings in Express Scripts were worth $1,331,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. TRUE Private Wealth Advisors bought a new stake in shares of Express Scripts during the 3rd quarter valued at about $115,000. Palo Capital Inc. bought a new position in Express Scripts in the 3rd quarter worth about $124,000. Landaas & Co. WI ADV bought a new position in Express Scripts in the 2nd quarter worth about $102,000. Kaizen Advisory LLC grew its position in Express Scripts by 147.6% in the 2nd quarter. Kaizen Advisory LLC now owns 1,342 shares of the company’s stock worth $104,000 after purchasing an additional 800 shares during the last quarter. Finally, Adviser Investments LLC grew its position in Express Scripts by 321.9% in the 2nd quarter. Adviser Investments LLC now owns 1,481 shares of the company’s stock worth $114,000 after purchasing an additional 1,130 shares during the last quarter. 84.74% of the stock is owned by institutional investors and hedge funds.
Several research firms have commented on ESRX. Barclays upped their target price on shares of Express Scripts from $83.00 to $90.00 and gave the stock an “equal weight” rating in a research report on Thursday. Royal Bank of Canada set a $101.00 target price on shares of Express Scripts and gave the stock a “buy” rating in a research report on Thursday. Leerink Swann set a $100.00 target price on shares of Express Scripts and gave the stock a “hold” rating in a research report on Thursday. Maxim Group restated a “hold” rating on shares of Express Scripts in a research report on Thursday. Finally, BidaskClub upgraded shares of Express Scripts from a “buy” rating to a “strong-buy” rating in a research report on Friday, October 12th. Two research analysts have rated the stock with a sell rating, twelve have given a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. Express Scripts presently has a consensus rating of “Hold” and an average target price of $88.79.
In other news, insider Christine Houston sold 12,898 shares of the company’s stock in a transaction that occurred on Friday, August 10th. The shares were sold at an average price of $85.00, for a total value of $1,096,330.00. Following the completion of the sale, the insider now directly owns 110,908 shares of the company’s stock, valued at approximately $9,427,180. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.79% of the company’s stock.
Shares of NASDAQ:ESRX opened at $97.24 on Friday. The company has a market capitalization of $53.64 billion, a PE ratio of 13.70, a P/E/G ratio of 1.20 and a beta of 1.01. Express Scripts Holding Co has a twelve month low of $59.17 and a twelve month high of $98.98. The company has a quick ratio of 0.59, a current ratio of 0.71 and a debt-to-equity ratio of 0.69.
Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings results on Wednesday, October 31st. The company reported $2.43 earnings per share for the quarter, topping analysts’ consensus estimates of $2.42 by $0.01. The company had revenue of $25.56 billion during the quarter, compared to analyst estimates of $25.11 billion. Express Scripts had a net margin of 4.65% and a return on equity of 25.49%. The business’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period in the prior year, the business posted $2.51 EPS. Equities analysts forecast that Express Scripts Holding Co will post 9.07 earnings per share for the current year.
About Express Scripts
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Featured Story: Outstanding Shares and The Effect on Share Price
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.